Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries MoonLake Immunotherapeutics - Class A Ordinary Shares (NQ: MLTX ) 47.48 +0.67 (+1.43%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 214,601 Open 46.70 Bid (Size) 44.62 (1) Ask (Size) 50.00 (1) Prev. Close 46.81 Today's Range 46.57 - 47.66 52wk Range 35.11 - 64.98 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News MoonLake Immunotherapeutics Announces Positive Regulatory Feedback from both FDA and EMA on Path for the Phase 3 Program for the Nanobody® sonelokimab in Psoriatic Arthritis June 10, 2024 From MoonLake Immunotherapeutics AG Via GlobeNewswire MoonLake Immunotherapeutics starts Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa May 16, 2024 From MoonLake Immunotherapeutics AG Via GlobeNewswire Performance YTD -20.27% -20.27% 1 Month +15.08% +15.08% 3 Month +15.69% +15.69% 6 Month -1.58% -1.58% 1 Year -15.50% -15.50% More News Read More MLTX Stock Earnings: MoonLake Misses EPS for Q1 2024 May 07, 2024 Via InvestorPlace MoonLake Immunotherapeutics Inks Three-Year Technology Partnership With Komodo Health To Advance Research on Inflammatory Skin and Joint Conditions April 10, 2024 From Komodo Health Via Business Wire Expert Ratings for MoonLake November 27, 2023 Via Benzinga Recap: MoonLake Q3 Earnings November 14, 2023 Via Benzinga Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session May 10, 2024 Via Benzinga MoonLake Jumps After Arthritis Drug Tops AbbVie Blockbuster Humira In A Key Test March 11, 2024 Via Investor's Business Daily 16 Analysts Have This to Say About MoonLake November 07, 2023 Via Benzinga Why Is Inflammatory Disease-Focused MoonLake Immunotherapeutics Stock Trading Higher Today? March 11, 2024 Via Benzinga MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day March 10, 2024 From MoonLake Immunotherapeutics AG Via GlobeNewswire MoonLake Immunotherapeutics to present MIRA trial data of Nanobody® sonelokimab in hidradenitis suppurativa as a late breaker at the AAD Annual Meeting 2024 March 04, 2024 From MoonLake Immunotherapeutics AG Via GlobeNewswire Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday March 01, 2024 Via Benzinga Topics Stocks Exposures US Equities MoonLake Immunotherapeutics Announces Positive Feedback from both FDA and EMA on Regulatory Path for the Phase 3 Program of the Nanobody® sonelokimab (SLK) in Hidradenitis Suppurativa (HS) February 26, 2024 From MoonLake Immunotherapeutics AG Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's After-Market Session December 20, 2023 Via Benzinga Why Former Highflier MoonLake Plummeted 29% After A Recent Run November 06, 2023 Via Investor's Business Daily Dow Turns Lower; EchoStar Shares Plunge November 06, 2023 Via Benzinga Topics Stocks Exposures US Equities Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session November 06, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session November 06, 2023 Via Benzinga Crude Oil Moves Higher; BioNTech Lowers 2023 Sales Outlook November 06, 2023 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Is Arthritis-Focused MoonLake Immunotherapeutics Stock Trading Lower Today? November 06, 2023 Via Benzinga TreeHouse Foods, EchoStar, Hilton Grand Vacations, EchoStar And Other Big Stocks Moving Lower On Monday November 06, 2023 Via Benzinga Topics Stocks Exposures US Equities US Stocks Rise; Nasdaq Gains 50 Points November 06, 2023 Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Monday's Pre-Market Session November 06, 2023 Via Benzinga MoonLake Immunotherapeutics announces landmark Phase 2 results for Nanobody® sonelokimab in active psoriatic arthritis November 05, 2023 From MoonLake Immunotherapeutics AG Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
